Clovis Oncology to Announce First Quarter 2013 Financial Results and Host Webcast Conference Call on May 7
Clovis Oncology, Inc. (Nasdaq:CLVS) will announce its first quarter 2013
financial results on Tuesday, May 7, 2013, before the open of the U.S.
financial markets. Clovis’ senior management will host a conference call
and live audio webcast on Tuesday, May 7, at 8:30 a.m. ET to discuss the
company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis
Oncology website at www.clovisoncology.com.
A replay of the webcast will be available for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops diagnostic tools that direct a
compound in development to the population that is most likely to benefit
from its use. Clovis Oncology is headquartered in Boulder, Colorado, and
has additional offices in San Francisco, California and Cambridge, UK.
